Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 109678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109678
Table 3 Incidence of hepatic encephalopathy following transjugular intrahepatic portosystemic shunt procedure with various stent diameters, n (%)
Type of stent | Incidence of hepatic encephalopathy |
Uncovered stent (n = 130) | 56/130 (43.1) |
Diameter of stent: 8 mm (n = 47) | 17/47 (36.1) |
Diameter of stent: 10 mm (n = 83) | 39/83 (47.0) |
Covered stent (n = 574) | 211/574 (36.8) |
Diameter of stent: 6 mm (n = 94) | 6/94 (6.4) |
Diameter of stent: 7 mm (n = 178) | 67/178 (37.6) |
Diameter of stent: 8 mm (n = 302) | 138/302 (45.7) |
- Citation: Zhang JQ, Cheng DL, Zhou CZ, Xu XJ. Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview. World J Hepatol 2025; 17(8): 109678
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/109678.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.109678